PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.53 USD | -0.43% |
|
-3.67% | -4.38% |
| 06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
| 06-14 | Pfizer: improved overall survival in myeloma | CF |
Presenter SpeechCharles Triano (Executives)Welcome back and thank you for joining us this morn...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
29/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53
USD
Average target price
31.92
USD
Spread / Average Target
+15.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.38% | 156B | |
| +41.10% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +17.45% | 246B | |
| 0.00% | 225B | |
| +10.32% | 218B | |
| +3.68% | 160B | |
| -3.88% | 116B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Transcript : Pfizer Inc. - Analyst/Investor Day